Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-24

FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (AvKARE)

View source ↗

Summary

FDA approved a supplemental application for a generic combination tablet of telmisartan and hydrochlorothiazide manufactured by AvKARE.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Hydrochlorothiazide (telmisartan and hydrochlorothiazide)

Snippet

SUPPL AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)